[Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters]

Rev Argent Microbiol. 2005 Oct-Dec;37(4):169-75.
[Article in Spanish]

Abstract

Leptospira serogroup Ballum is at present the first cause of human leptospirosis in Cuba. Killed whole-cell vaccines were formulated with two clinical isolates of Leptospira interrogans serogroup Ballum using aluminum hydroxide as adjuvant. Agglutinins levels induced by each vaccine in hamsters were estimated by microscopic agglutination test and specific IgG activities were quantified by a whole cell-based enzyme-linked immunosorbent assay. Homologous and cross protective capacity against lethal and sublethal infection were determined in vaccinated animals by challenge with 100 and 10,000 LD50 of five virulent strains belonging to serogroups Ballum, Canicola, Icterohaemorrhagiae and Pomona. Both monovalent serogroup Ballum vaccines were immunogenic and induced complete homologous protection in the animal model. Cross-protection was only significant in one of the two vaccines against challenge with 100 LD50 of serogroup Canicola. The results of this study demonstrate the high immunogenicity and protective capacity in hamsters of whole-cell monovalent vaccines formulated with two vaccine candidate strains belonging to the most prevalent serogroup of Leptospira in Cuba.

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood
  • Antibodies, Bacterial / immunology
  • Bacterial Vaccines / immunology*
  • Cricetinae
  • Drug Evaluation, Preclinical
  • Immunoglobulin G / blood
  • Leptospira interrogans / immunology*
  • Leptospira interrogans serovar canicola / immunology
  • Leptospira interrogans serovar icterohaemorrhagiae / immunology
  • Leptospira interrogans serovar pomona / immunology
  • Leptospirosis / prevention & control*
  • Mesocricetus
  • Vaccination

Substances

  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Immunoglobulin G